Anemia before and during concurrent chemoradiotherapy in patients with cervical carcinoma: Effect on progression-free survival.

@article{Obermair2003AnemiaBA,
  title={Anemia before and during concurrent chemoradiotherapy in patients with cervical carcinoma: Effect on progression-free survival.},
  author={Andreas Obermair and Robyn Cheuk and Keith Horwood and Meira Neudorfer and Monika Janda and Giorgos Giannis and James L Nicklin and Lewis Perrin and Alex Crandon},
  journal={International journal of gynecological cancer : official journal of the International Gynecological Cancer Society},
  year={2003},
  volume={13 5},
  pages={633-9}
}
To determine the impact of anemia before and during chemoradiation in patients with cervical cancer, we collected data on hemoglobin (Hb) levels before and during treatment from 60 unselected patients with cervical carcinoma. All patients had FIGO stage IB to IVA disease and were treated with concurrent chemoradiation for the aim of cure. Patients with an Hb value below or equal to the lower 25th quartile were considered anemic. Progression-free survival (PFS) was evaluated by univariate and… CONTINUE READING
12 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 12 extracted citations

Similar Papers

Loading similar papers…